Kaposi's sarcoma of the oral cavity in renal transplanted patient; a case report

Kaposi's sarcoma was first descrided by Kaposi in 1872 as an idiopathic multiple hemorrhagic sarcoma. Its clinical features revealed to be erythematous red or purple macule started out, and developing into palpable dome-shaped nodules. Etiology is not defined to detail at present. Kaposi's sarcoma is classified to 4 categories; Classical, African, Epidemic and Transplant type. Epidemic or AIDS categories is found approximately 20 % of all AIDS and has strong predilection for head and neck region. The first case of Kaposi's sarcoma observed in patients with kidney transplants was reported in 1969. Kaposi's sarcoma now accounts for 5% of all tumors associated with transplanted patients and alteration of the immunosuppression may have played a key role in these recipients. The most common site of Kaposi's sarcoma in transplanted patients are extremities but rare in head and neck area. We report a case of Kaposi's sarcoma on the hard palate in the kidney transplantation patient.

A case of odontogenic myxoma related to both impacted canine teeth in the mandible

Odontogenic myxoma is a rare tumor which occurs almost exclusively in the jaws, and seems to be of odontogenic origin. Clinically this tumor tends to appear in the second and third decades of life, and most of the lesions are located in the premolar - molar region. It is characterized grossly by mucoid or gelatinous gray-whitish tissue that replaces the cancellous bone and expands the cortex. It is invasive locally and has a high recurrence rate ranging from 10% to 33%. Radiographically, the appearance of this tumor is varied, but usually appears as a unilocular or multilocualr radioluscency of varying size. We experienced a rare case of odontogenic myxoma 12 years old patient related to mandibular bilateral impacted canines in the mandible, so we report this case with literature.

Clinical study of resorbable plate and screw for treatment of maxillofacial fractures

PURPOSE: This study evaluated the usefulness of resorbable plate and screw for treatment of maxillofacial bone fractures. PATIENTS AND METHODS: From july, 2000 to july, 2002, we used resorbable plates and screws(Biosorb. FX, Bionix Inc, Finland) on 126 patients for treatment of maxillofacial bone fractures. Among them, 80 patients were capable of periodic following up to present season. We evaluated these patients with clinical, radiographic findings and subjective satisfaction. RESULTS: 80 patients composed of 63 men and 17 women. Complication rates are 7.5%(6/80) recorded. 1 of bulging sensation, 3 of infection sign, 2 of the plate detachment were shown. The plates involved in such complications were removed. The other patients(92.5%) were not shown any problems. We could not find complete resorption of screw holes in the mandibular symphysis area even though two years later after surgery. CONCLUSION: Bioresorbable plates and screws are useful as fixation material at maxillofacial fractures although strength is thought to be weaker than titanium plate. But to reduce the possible complicaions, need to careful clinical and radiographical evaluations.